<DOC>
	<DOCNO>NCT00748852</DOCNO>
	<brief_summary>The purpose study evaluate safety JTT-302 administer eight 12 week subject low HDL-C level determine effect JTT-302 lipid parameter CETP activity mass .</brief_summary>
	<brief_title>Safety Study JTT-302 Subjects With Low HDL-C Levels</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Subjects must successfully complete 4week treatment period study AT302U06003 Females pregnant lactating , females child bear potential use effective method contraception Use Cytochrome P450 3A4 inducer inhibitor , define protocol Subjects follow prescription OTC medication restriction define protocol Flushots permit study , include followup period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>